...
首页> 外文期刊>Japanese journal of clinical oncology. >Impact of advanced age on biochemical recurrence after radical prostatectomy in Japanese men according to pathological stage
【24h】

Impact of advanced age on biochemical recurrence after radical prostatectomy in Japanese men according to pathological stage

机译:病理分级对日本男性根治性前列腺切除术后高龄对生化复发的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: To determine the impact of advanced age as a predictor of biochemical recurrence after radical prostatectomy in Japanese patients with regard to pathological stage. Methods: We retrospectively evaluated 379 Japanese patients with pT2-3N0/X prostate cancer undergoing radical prostatectomy from 2000 to 2010 at a single academic institution. Cox proportional hazards model was used to determine whether advanced age is a predictor of biochemical recurrence according to pathological stage. Results: The mean age at radical prostatectomy was 65.8 years. With a mean follow-up of 49.8 months, 61 men (16.1%) experienced biochemical recurrence. Martingale residual analysis showed that the adverse prognostic effect of age on biochemical recurrence fits a linear model, and patients were classified into two groups using a cut-off point of age 70 years. Although older patients had higher rates of biochemical recurrence than younger ones in the case of pT2 patients (P =0.049), advanced age itself was not an independent predictor of biochemical recurrence among the total cohort. However, especially in pT2 patients with negative surgical margins, advanced age was an independent predictor of biochemical recurrence (HR =3.97, P =0.006). In these patients, 2- and 5-year biochemical recurrence- free survival rates were 98.0 and 92.4% for younger patients and 93.2 and 82.0% for older patients, respectively (log-rank P =0.015). On the other hand, in pT3 patients, there was no significant association between age and biochemical recurrence.Conclusions: Advanced age is an independent predictor of biochemical recurrence after radical prostatectomy in Japanese patients with stage pT2 disease and negative surgical margins. Moreover, older patients of this group tended to have recurrence more than 2 years after surgery.
机译:目的:确定高龄作为根治性前列腺切除术后日本患者生化复发的病理因素。方法:我们回顾性评估了2000年至2010年在单一学术机构中接受根治性前列腺切除术的379例日本pT2-3N0 / X前列腺癌患者。使用Cox比例风险模型根据病理分期确定高龄是否是生化复发的预测因子。结果:前列腺癌根治术的平均年龄为65.8岁。平均随访49.8个月,有61名男性(16.1%)经历了生化复发。 ting残差分析表明,年龄对生化复发的不良预后符合线性模型,并且使用70岁的临界值将患者分为两组。尽管在pT2患者中老年患者的生化复发率高于年轻患者(P = 0.049),但高龄本身并不是整个队列中生化复发的独立预测因子。但是,特别是在手术切缘阴性的pT2患者中,高龄是生化复发的独立预测因子(HR = 3.97,P = 0.006)。在这些患者中,年轻患者的2年和5年无生化复发生存率分别为98.0%和92.4%,老年患者分别为93.2%和82.0%(对数秩P = 0.015)。另一方面,在pT3患者中,年龄与生化复发之间无显着相关性。结论:高年龄是日本pT2期疾病和手术切缘阴性的患者在前列腺癌根治术后生化复发的独立预测因子。此外,该组中的老年患者往往在手术后两年以上复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号